Computational and systems approaches to early stage drug discovery
- Computational methods can potentially improve target identification and validation at the earliest possible stage of drug development by providing a better understanding of the biology of the target network. Such a knowledge should also lead to new therapeutic strategies based on molecular mechanisms.
Discovery of drug targets
- Our goal is to discover novel drug targets by utilizing cutting-edge techniques in bioinformatics and computational biology.
New therapeutic strategies based on molecular mechanisms
- Our research is aimed at accelerating drug discovery by computational approaches towards a systems-level understanding of biological molecules, their reactions and diseases. We have successfully identified and designed compounds with physiological activities based solely on in silico prediction. Also we are developing a range of computational biology techniques, utilizing information about protein sequence, structure and interaction.
- Development of in silico screening methods
- See the Center for Drug Design Research(CDDR) page
- Prediction of protein-protein interactions with an application to breast cancer therapies
- Enzyme structures and functions
Biomarker discovery and toxicity prediction
- We are developing databases for biomarker discovery and toxicity prediction.